PCN93 - Treatment Practice Patterns, Healthcare Resource Utilization (HRU), and Costs in Newly Diagnosed Patients with Therapy-Related Acute Myeloid Leukemia (TAML) or AML with Myelodysplasia-Related Changes (AML-MRC) in a United States (US) Commercially Insured Population

Autor: Hagiwara, M, Sharma, A, Chung, KC, Delea, TE
Zdroj: In Value in Health May 2018 21 Supplement 1:S27-S27
Databáze: ScienceDirect
Externí odkaz: